AI-powered search
AI-powered search

2023 Fall Clinical Virtual Grand Rounds

2023 Virtual Grand Rounds Session 17: December 13, 2023 - Managing Vitiligo and Other Pigmentary Disorders; What You Need to Know NOW About Alopecia Areata


Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:

Wednesday, December 13, 2023

8 PM ET / 5 PM PT

Managing Vitiligo and Other Pigmentary Disorders 

What You Need to Know Now About Alopecia Areata 


In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

December 14, 2023

Expiration Date:

December 14, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Discuss current and emerging data for the treatment of vitiligo and hyperpigmentation disorders.

  • Identify safe and effective treatment options for non-segmental vitiligo and melasma.

  • Translate safety and efficacy data on JAK Inhibitors for the management of alopecia areata (AA)

  • Describe strategies to individualize care when using new treatments for the management AA

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Andrew Alexis, MD, MPH

Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology 
Weill Cornell Medicine
New York, NY

April Armstrong, MD, MPH

Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Natasha Mesinkovska, MD, PhD

Vice Chair, Clinical Research 
University of California Irvine
Irvine, CA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Andrew F. Alexis, MD, MPH

Grant/Research Support: BMS, LEO, Novartis, Almirall

Consultant: Leo, Galderma, Pfizer, Sanofi- Regeneron

Speakers’ Bureau or Honoraria: Regeneron, SANOFI-Genzyme, Pfizer, BMS

April W. Armstrong, MD, MPH

Grant/Research Support: BMS, Leo, UCB, Lilly, Dermavant, Dermira, Pfizer, AbbVie, ASLAN, BI, EPI, Incyte, Janssen 

Consultant: Lilly, Novartis, Ortho, SUN, Dermavant, Dermira, Sanofi Regeneron, Pfizer, Parexel 

Natasha A. Mesinkovska, MD, PhD

Advisory Board: Pfizer, Lilly, Concert, Abbvie, Galderma

Grant/Research Support: Pfizer

Consultant: National Alopecia Areata Foundation

Speakers’ Bureau or Honoraria: Lilly

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved